The Latest Cardiac and Vascular News
Mavacamten Is a Potential First-in-Class Medicine with Compelling Data in the Treatment of Patients with Symptomatic Obstructive Hypertrophic Cardiomyopathy Mavacamten Will Be a Medium- and Long-Term Growth Driver Presenting a Significant Commercial Opportunity upon Approval Promising Portfolio of Pipeline Candidates Strengthens and Extends Bristol Myers Squibb’s Leading Cardiovascular Franchise Expected to […]
BELOIT, Wis.–(BUSINESS WIRE)–NorthStar Medical Technologies, LLC, a global innovator in the development, production and commercialization of diagnostic and therapeutic radiopharmaceuticals, today announced the promotion of Chief Financial Officer Paul Estrem, to Executive Vice President. Mr. Estrem has also been appointed to the NorthStar Board of Managers, effective October 12, 2020, […]
SAN RAMON, Calif.–(BUSINESS WIRE)–BioVentrix, Inc., a privately held medical device company focused on treating congestive heart failure (CHF) via Transcatheter Ventricular Restoration (TCVR), today announced that Chris Wolff has been named Vice President of U.S. Sales. In this role, Mr. Wolff will be responsible for driving enrollment in the ongoing ALIVE Trial […]
SUNNYVALE, Calif., Oct. 01, 2020 (GLOBE NEWSWIRE) — Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced that medical device industry veteran Rick Anderson has joined its board of directors. Anderson brings over 30 years of senior executive […]
– Combined portfolio will enhance Mentice’s endovascular simulation offerings with world class replication solutions – Acquisition to expand Mentice’s global customer base and offer a strong entry into previously untapped market segments STOCKHOLM, Oct. 1, 2020 /PRNewswire/ — Mentice AB (STO: MNTC) today signed a definitive agreement to acquire the New York-based medical […]
BOSTON, Oct. 1, 2020 /PRNewswire/ — Dyad Medical, Inc., a groundbreaking medical image analysis platform delivering cloud-based artificial intelligence (AI)-based analysis, announced after just 90 days, the closing of its oversubscribed Series Seed funding round led by The Unofficial Syndicate, with participation by Social Starts L.P., and local angel investors. Along with grants […]
Funding Will Support Clinical Trials to Evaluate the Company’s Novel Treatment for Peripheral Artery Disease SALT LAKE CITY–(BUSINESS WIRE)–Alucent Biomedical, a privately held medical technology company founded to transform the way vascular disease is treated, today announced the close of a $35 million Series B financing round led by a […]
Avenu’s Percutaneous Fistula Creation Technology Will Strengthen the Medtronic Peripheral Vascular Access Portfolio and Reinforce Medtronic’s Commitment to Improving Outcomes for Patients with End-Stage Renal Disease DUBLIN, Sept. 30, 2020 /PRNewswire/ — Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced the planned acquisition of Avenu Medical, a privately held medical […]
New York, Sept. 29, 2020 (GLOBE NEWSWIRE) — Univest Securities, LLC, a member of FINRA and SIPC, is a full-service investment bank and securities broker-dealer firm based in New York, today announced the closing for the acquisition of Somulation, Inc. by its client Marizyme, Inc. (OTC:MRZM) (“Marizyme” or the “Company”), […]
Fiscal 2021 First Quarter Highlights Net sales of $70.2 million increased 6.3% compared to the prior-year quarter, inclusive of the previously disclosed $5.2 million order from the National Health Service (NHS) in the UK Gross margin declined 700 basis points year over year to 50.9% GAAP loss per share of […]
